Dr. Lal Pathlabs Ltd.

NSE: LALPATHLAB | BSE: 539524 | ISIN: INE600L01024 | Industry: Healthcare Services
| Expensive Performer
2779.8000 -27.30 (-0.97%)
NSE May 13, 2025 15:31 PM
Volume: 126.2K
 

2779.80
-0.97%
Geojit BNP Paribas
With persistent focus of service parameters and timely turnarounds, DLPL was able to achieve robust growth in volume during the pandemic. Leveraging its dedicated network driven infrastructure and techenabled processes, we expect the company to be able to perform well in the expected third wave situation. Hence, we upgrade our rating on the...
Dr. Lal Pathlabs Ltd. has an average target of 2923.50 from 4 brokers.
More from Dr. Lal Pathlabs Ltd.
Recommended